MedTrace Logo

Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention

NCT03627455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 818

Last updated 2018-08-14

No results posted yet for this study

Summary

Elevated levels of troponin are associated with future MACE. Data on the prognostic value of high sensitive troponin T (hs-TnT) as compared to high sensitive troponin I (hs-TnI) in diabetic and non-diabetic patients are sparse.

We aimed to assess the risk for MACE according to gender and diabetes status and to compare the prognostic value of hs-TnT and hs-TnI with regards to clinical outcomes in diabetic and non-diabetic patients undergoing percutaneous coronary intervention (PCI).

Conditions

Interventions

OTHER

Percutaneous coronary intervention

Percutaneous coronary intervention

Sponsors & Collaborators

  • Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology

    collaborator OTHER

  • Wilhelminenspital Vienna

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03627455 on ClinicalTrials.gov